Depression and Stimulant Dependence: Neurobiology and Pharmacotherapy
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Depressive disorder rates in stimulant-dependent individuals are substantially higher than community rates. Further, depressive symptoms are considered a major component of stimulant withdrawal. The comorbidity of these disorders may reflect shared neurochemical alterations in the function of serotonin, dopamine, and peptide systems, such as corticotropin releasing factor (CRF) and neuropeptide Y (NPY). These alterations are observed in patients, and in animal models of depression and stimulant dependence, particularly in limbic brain structures. This shared neurobiology does not seem to result from significant shared heritability or genetic linkage; stimulants may induce changes in neurobiology that are similar to those found in depression, and these changes might provide a therapeutic target. Stimulant-dependent patients with a depressive disorder may be a specific subpopulation for antidepressant trials, and they might reduce their stimulant abuse when treated with antidepressants. Nevertheless, concomitant dependence on alcohol or opioids may influence this response, and antidepressants appear to be more effective for depression in combined stimulant and opioid dependence than in combined stimulant and alcohol dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationNemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230
Alcohol problems in adoptees raised apart from alcoholic biological parents
Goodwin, D. W. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750320068011 · Cited by 882
Low level of response to alcohol as a predictor of future alcoholism
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.2.184 · Cited by 826
Adult Outcomes of Childhood and Adolescent Depression: I. Psychiatric Status
Harrington, R. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170065010 · Cited by 764
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
Self-citationPsychiatric Diagnoses of Treatment-Seeking Cocaine Abusers
Rounsaville, B. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250045005 · Cited by 605
Effects of chronic cocaine abuse on postsynaptic dopamine receptors
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.6.719 · Cited by 421
Research works printed but not linked: 98
- Arato, 1989, Biol Psychiatry, 25, 355, 10.1016/0006-3223(89)90183-2 · DOI · Paper page
- Batki, 1988, J Psychoactive Drugs, 20, 213, 10.1080/02791072.1988.10524497 · DOI
- Batki, 1996, Drug Alcohol Depend, 41, 137, 10.1016/0376-8716(96)01233-1 · DOI
- Bel, 1993, Synapse, 15, 243, 10.1002/syn.890150310 · DOI · Paper page
- Benloucif, 1993, J Pharmacol Exp Ther, 265, 373
- Blier, 1994, Trends Pharmacol Sci, 15, 220, 10.1016/0165-6147(94)90315-8 · DOI · Paper page
- Bokstrom, 1992, Alcohol Clin Exp Res, 16, 241, 10.1111/j.1530-0277.1992.tb01370.x · DOI · Paper page
- Branchey, 1984, Am J Psychiatry, 141, 1212, 10.1176/ajp.141.10.1212 · doi:10.1176/ajp.141.10.1212
- Brown, 1998, Am J Psychiatry, 155, 220, 10.1176/ajp.155.2.220 · DOI · Paper page
- Cadoret, 1985, J Affect Disord, 9, 155, 10.1016/0165-0327(85)90095-3 · DOI
- Carroll, 1995, J Nerv Ment Dis, 183, 251, 10.1097/00005053-199504000-00012 · DOI · Paper page
- Carroll, 1993, J Nerv Ment Dis, 181, 71, 10.1097/00005053-199302000-00001 · DOI · Paper page
- Carroll, 1994, Arch Gen Psychiatry, 51, 177, 10.1001/archpsyc.1994.03950030013002 · DOI · Paper page
- Ciraulo, 1981, J Clin Psychopharmacol, 1, 146, 10.1097/00004714-198105000-00006 · DOI
- Cornelius, 1995, Psychopharmacol Bull, 31, 297
- Covi, 1995, Am J Drug Alcohol Abuse, 21, 327, 10.3109/00952999509002701 · DOI · Paper page
- Dackis, 1984, Am J Psychiatry, 141, 810, 10.1176/ajp.141.6.810 · DOI
- de Montigny, 1978, Science, 202, 1303, 10.1126/science.725608 · DOI · Paper page
- Deykin, 1992, Am J Psychiatry, 149, 1341, 10.1176/ajp.149.10.1341 · DOI · Paper page
- France, 1988, Biol Psychiatry, 23, 86, 10.1016/0006-3223(88)90108-4 · DOI
- Galloway, 1994, J Addict Dis, 13, 201, 10.1300/J069v13n04_08 · DOI · Paper page
- Gawin, 1986, Arch Gen Psychiatry, 43, 107, 10.1001/archpsyc.1986.01800020013003 · DOI · Paper page
- Gjerris, 1992, J Psychiatry Neurosci, 17, 23
- Goeders, 1990, Brain Res, 531, 322, 10.1016/0006-8993(90)90794-C · DOI
- Grabowski, 1995, J Clin Psychopharmacol, 15, 163, 10.1097/00004714-199506000-00004 · DOI · Paper page
- Gurling, 1984, Acta Genet Med Gemellol, 33, 333, 10.1017/S0001566000007376 · DOI · Paper page
- Heilig, 1994, Trends Neurosci, 17, 80, 10.1016/0166-2236(94)90079-5 · DOI · Paper page
- Heilig, 1990, Acta Psychiatr Scand, 82, 95, 10.1111/j.1600-0447.1990.tb01366.x · DOI · Paper page
- Hurt, 1997, N Engl J Med, 337, 1195, 10.1056/NEJM199710233371703 · DOI · Paper page
- Janowsky, 1982, Science, 218, 900, 10.1126/science.6291152 · DOI · Paper page
- Kendler, 1993, Arch Gen Psychiatry, 50, 690, 10.1001/archpsyc.1993.01820210024003 · DOI · Paper page
- Kendler, 1995, Arch Gen Psychiatry, 52, 374, 10.1001/archpsyc.1995.03950170048007 · DOI · Paper page
- Kessler, 1994, Arch Gen Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
- Kilbey, 1992, Drug Alcohol Depend, 29, 283, 10.1016/0376-8716(92)90103-J · DOI
- Kleber, 1983, Arch Gen Psychiatry, 40, 649, 10.1001/archpsyc.1983.04390010059007 · DOI · Paper page
- Kleinman, 1990, J Nerv Ment Dis, 178, 442, 10.1097/00005053-199007000-00005 · DOI · Paper page
- Koob, 1993, Semin Neurosci, 5, 351, 10.1016/S1044-5765(05)80043-0 · DOI
- Kosten, 1992, Arch Gen Psychiatry, 49, 894, 10.1001/archpsyc.1992.01820110058009 · DOI · Paper page
- Kranzler, 1992, Am J Drug Alcohol Abuse, 18, 187, 10.3109/00952999208992831 · DOI
- Lin, 1996, Drug Alcohol Depend, 43, 49, 10.1016/S0376-8716(96)01287-2 · DOI · Paper page
- Linnoila, 1994, EXS, 71, 155
- Liskow, 1987, J Stud Alcohol, 48, 356, 10.15288/jsa.1987.48.356 · DOI · Paper page
- Malison, 1995, Psychopharmacology, 122, 358, 10.1007/BF02246266 · DOI
- Manier, 1984, Experientia, 40, 1223, 10.1007/BF01946651 · DOI
- Manier, 1987, Biochem Pharmacol, 36, 3308, 10.1016/0006-2952(87)90650-2 · DOI
- Markou, 1991, Neuropsychopharmacology, 4, 17
- Markou, 1998, Neuropsychopharmacology, 18, 135, 10.1016/S0893-133X(97)00113-9 · DOI · Paper page
- Mason, 1996, JAMA, 275, 761, 10.1001/jama.275.10.761 · DOI
- McGrath, 1996, Arch Gen Psychiatry, 53, 232, 10.1001/archpsyc.1996.01830030054009 · DOI · Paper page
- McIntyre, 1984, Biol Psychiatry, 19, 1725
- Mendelson, 1988, Am J Psychiatry, 145, 1094, 10.1176/ajp.145.9.1094 · DOI · Paper page
- Merikangas, 1990, Psychiatr Clin North Am, 13, 613, 10.1016/S0193-953X(18)30339-3 · DOI · Paper page
- Myers, 1984, Arch Gen Psychiatry, 41, 959, 10.1001/archpsyc.1984.01790210041006 · DOI · Paper page
- Nemeroff, 1988, Arch Gen Psychiatry, 45, 577, 10.1001/archpsyc.1988.01800300075009 · DOI · Paper page
- Nomikos, 1991, Eur J Pharmacol, 195, 63, 10.1016/0014-2999(91)90382-Z · DOI · Paper page
- Nunes, 1995, Drug Alcohol Depend, 39, 185, 10.1016/0376-8716(95)01161-6 · DOI · Paper page
- Nunes, 1993, Am J Psychiatry, 150, 963, 10.1176/ajp.150.6.963 · DOI · Paper page
- Nunes, 1994, J Addict Dis, 13, 13, 10.1300/J069v13n03_02 · doi:10.1300/j069v13n03_02
- Nunes, 1991, Am J Psychiatry, 148, 667, 10.1176/ajp.148.5.667 · DOI
- Nunes, 1998, Arch Gen Psychiatry, 55, 153, 10.1001/archpsyc.55.2.153 · DOI · Paper page
- Olivera, 1991, Am J Drug Alcohol Abuse, 17, 295, 10.3109/00952999109027553 · DOI
- Owens, 1991, Pharmacol Rev, 43, 425
- Parsons, 1993, Brain Res, 606, 195, 10.1016/0006-8993(93)90984-U · DOI · Paper page
- Parsons, 1995, J Pharmacol Exp Ther, 274, 1182
- Parsons, 1991, Synapse, 9, 60, 10.1002/syn.890090109 · DOI · Paper page
- Paul, 1988, J Pharmacol Exp Ther, 246, 956
- Peroutka, 1980, Science, 210, 88, 10.1126/science.6251550 · DOI · Paper page
- Pickens, 1991, Arch Gen Psychiatry, 48, 19, 10.1001/archpsyc.1991.01810250021002 · DOI · Paper page
- Reich, 1993, J Am Acad Child Adolesc Psychiatry, 32, 995, 10.1097/00004583-199309000-00017 · DOI · Paper page
- Richter, 1995, Neurosci Lett, 187, 169, 10.1016/0304-3940(95)11365-4 · DOI
- Rossetti, 1992, Ann NY Acad Sci, 654, 513, 10.1111/j.1749-6632.1992.tb26016.x · DOI
- Rounsaville, 1987, Arch Gen Psychiatry, 44, 505, 10.1001/archpsyc.1987.01800180015002 · DOI · Paper page
- Rounsaville, 1982, Arch Gen Psychiatry, 39, 161, 10.1001/archpsyc.1982.04290020027006 · DOI · Paper page
- Roy, 1987, Prog Neuro-Psychopharmacol Biol Psychiatry, 11, 173, 10.1016/0278-5846(87)90056-X · DOI
- Satel, 1993, Am J Psychiatry, 150, 695, 10.1176/ajp.150.5.695 · DOI · Paper page
- Satel, 1991, Am J Psychiatry, 148, 1712, 10.1176/ajp.148.12.1712 · DOI · Paper page
- Schuckit, 1986, Am J Psychiatry, 143, 140, 10.1176/ajp.143.2.140 · DOI · Paper page
- Stockmeier, 1985, Science, 230, 323, 10.1126/science.2996132 · DOI
- Targum, 1982, J Affect Dis, 4, 347, 10.1016/0165-0327(82)90030-1 · DOI
- Titievsky, 1982, J Clin Psychiatry, 43, 454
- Tsuang, 1996, Am J Med Genet, 67, 473, 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.0.CO;2-L · DOI · Paper page
- Turkka, 1990, Eur J Pharmacol, 177, 171, 10.1016/0014-2999(90)90267-A · doi:10.1016/0014-2999(90)90267-a
- Von Knorring, 1983, Arch Gen Psychiatry, 40, 943, 10.1001/archpsyc.1983.01790080025003 · DOI · Paper page
- Wahlestedt, 1990, Brain Res, 507, 65, 10.1016/0006-8993(90)90523-E · DOI · Paper page
- Wang, 1980, Commun Psychopharmacol, 4, 83
- Weddington, 1990, Arch Gen Psychiatry, 47, 861, 10.1001/archpsyc.1990.01810210069010 · DOI · Paper page
- Weddington, 1991, Am J Drug Alcohol Abuse, 17, 137, 10.3109/00952999108992817 · DOI · Paper page
- Weiss, 1992, J Neurosci, 12, 4372, 10.1523/JNEUROSCI.12-11-04372.1992 · DOI · Paper page
- Weiss, 1992, Br J Addict, 87, 179, 10.1111/j.1360-0443.1992.tb02691.x · DOI · Paper page
- Weiss, 1986, Am J Drug Alcohol Abuse, 12, 17, 10.3109/00952998609083740 · DOI · Paper page
- Wender, 1986, Arch Gen Psychiatry, 43, 923, 10.1001/archpsyc.1986.01800100013003 · DOI · Paper page
- Widerlov, 1988, J Psychiatr Res, 22, 69, 10.1016/0022-3956(88)90030-1 · DOI · Paper page
- Willner, 1985, Psychopharmacology, 85, 387, 10.1007/BF00429653 · DOI · Paper page
- Willner, 1994, Psychopharmacology, 115, 454, 10.1007/BF02245568 · DOI
- Woody, 1982, Ann NY Acad Sci, 398, 120, 10.1111/j.1749-6632.1982.tb39485.x · DOI
- Woody, 1975, Am J Psychiatry, 132, 447, 10.1176/ajp.132.4.447 · DOI · Paper page
- Ziedonis, 1991, Psychopharmacol Bull, 27, 337
- Zisook, 1987, J Stud Alcohol, 48, 337, 10.15288/jsa.1987.48.337 · doi:10.15288/jsa.1987.48.337
Cited by
Treating Drug Abuse and Addiction in the Criminal Justice System: Improving Public Health and Safety
Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009) · JAMA · doi:10.1001/jama.2008.976 · Cited by 583
“Additionally, repeated drug use also affects brain regions implicated in mood and anxiety, which could explain the high rate of addiction comorbid with dysphoria, depression, or both and the vulnerabilityof theaddictedpersontorelapsewhen exposed to social stressors.(65,66) Impairment of the neural substrates affected…”
BackgroundThe nature, time course and severity of methamphetamine withdrawal
McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01160.x · Cited by 458
Neuropeptide Y: the universal soldier
Pedrazzini, T., Pralong, F., & Grouzmann, E. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180300029 · Cited by 286
Ersche, K. D., Turton, A. J., Chamberlain, S. R., Müller, U., Bullmore, E. T., & Robbins, T. W. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11091421 · Cited by 252
“Depressive symptoms have been associated with both intoxication and withdrawal from various addictive drugs (28, 29), possibly resulting from druginduced changes in monoamine neurotransmission (29, 30).”
BackgroundDelay discounting predicts postpartum relapse to cigarette smoking among pregnant women.
Yoon, J. H., Higgins, S. T., Heil, S. H., Sugarbaker, R. J., Thomas, C. S., & Badger, G. J. (2007) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.15.2.186 · Cited by 206
Metadata
- Authors
- KOSTEN, T. R., MARKOU, A., & KOOB, G. F.
- Venue
- The Journal of Nervous & Mental Disease
- Published
- 1998-12
- Volume
- 186
- Issue
- 12
- Pages
- 737-745
- ISSN
- 0022-3018 (ISSN-L)
- OpenAlex
- W1965857014
- Cited by
- 77
- References
- 19
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression and Stimulant Dependence: Neurobiology and Pharmacotherapy. https://app.cochat.ai/papers/10.1097/00005053-199812000-00001
- The paper
- KOSTEN, T. R., MARKOU, A., & KOOB, G. F. (1998). Depression and Stimulant Dependence: Neurobiology and Pharmacotherapy. The Journal of Nervous & Mental Disease. https://doi.org/10.1097/00005053-199812000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.